Rocket


News + Filings
Transactions
Holdings


All
13F
13D/G
Other

Lynx1 Capital Management LP Create: Alert

All | News | Filings
Date FiledTypeDescription
06/02/2023 SC 13G Lynx1 Capital Management LP reports a 12.2% stake in TScan Therapeutics, Inc.
02/14/2023 SC 13G/A Lynx1 Capital Management LP reports a 9.7% stake in Cabaletta Bio, Inc.
02/14/2023 SC 13G/A Lynx1 Capital Management LP reports a 6.2% stake in Passage BIO, Inc.
02/14/2023 SC 13G/A Lynx1 Capital Management LP reports a 7.6% stake in Pieris Pharmaceuticals, Inc.
02/14/2023 SC 13G/A Lynx1 Capital Management LP reports a 6.8% stake in Alpine Immune Sciences, Inc.
01/23/2023 SC 13G Lynx1 Capital Management LP reports a 5% stake in Kinnate Biopharma Inc.
01/23/2023 SC 13G Lynx1 Capital Management LP reports a 5% stake in Neoleukin Therapeutics, Inc.
12/30/2022 SC 13G Lynx1 Capital Management LP reports a 5.4% stake in Neoleukin Therapeutics, Inc.
10/24/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
09/29/2022 SC 13G Lynx1 Capital Management LP reports a 5.1% stake in Passage BIO, Inc.
04/22/2022 SC 13G Lynx1 Capital Management LP reports a 5.1% stake in Alpine Immune Sciences, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy